The pathogenesis of IgA nephropathy

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 2, 2011, Pages 153-160

  Glassock, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IgA glycosylation; IgA nephropathy; immune complexes

Indexed keywords

GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; SIALYLTRANSFERASE;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNITY; CHROMOSOME 6; CLINICAL FEATURE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONFORMATIONAL TRANSITION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME STRUCTURE; EXPERIMENTAL ANIMAL; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GLOMERULOPATHY; GLOMERULUS; HERITABILITY; HLA SYSTEM; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KIDNEY BIOPSY; MOLECULAR MIMICRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN AGGREGATION; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A;

EID: 79952038719     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283436f5c     Document Type: Article

References (78)

1. Berger J, Hinglais N. Les depots intercapillaries d'IgA-IgG. J Urol Nephrol 1968; 74:694-695.
2. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64:709-727. (Pubitemid 18047151)
3. Lai KN, editor. Recent advances in IgA nephropathy. Singapore: World Scientific; 2009.
4. Tomino Y, editor. IgA nephropathy today. Contrib Nephrol 2007; 157:1-243.
5. Briganti EM, Dowling J, Finaly M, et al. The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant 2001; 16:1364-1367. (Pubitemid 32640589)
6. McGrogan A, Franssen CFM, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 2010 [Epub ahead of print].
7. Julian BA,Wyatt RJ,WaldoFB, et al. Immunological studies of IgA nephropathy: familial and racial aspects. Adv Exp Med Biol 1987; 116B:1489-1498.
8. Glassock RJ. Future prospects for IgA nephropathy. In: Lai KN, editor. Recent advances in IgA nephropathy. Singapore: World Scientific; 2009. pp. 403- 412.
9. Clarkson AR, Seymour AE, Thompson AJ, et al. IgA nephropathy: a syndrome of uniform morphology, diverse clinical feaures and uncertain prognosis. Clin Nephrol 1977; 8:459-471. (Pubitemid 8233936)
10. Tomino Y. Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment of patients with immunoglobulin A nephropathy. Nephrology (Carlton) 2010; 15:1-6.
11. Suzuki Y, Tomino Y. Experimental model of IgA nephropathy. In: Lai KN, editor. Recent advances in IgA nephropathy. Singapore: World Scientific; 2009. pp. 387-402.
12. Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura and systemic lupus erythematosus. J Clin Invest 1980; 66:1432-1436. (Pubitemid 11205607)
13. Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol Rev 2006; 206:64-82. (Pubitemid 41105163)
14. Novak J, Julian BA, Tomana M, Mestecky J. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 2008; 28:78-87.
15. Tarelli E, Smith AC, Hendry BM, et al. Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Carbohydr Res 2004; 339:2329-2335. (Pubitemid 39165126)
16. Oortwijn BD, Rastaldi MP, Roos A, et al. Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. Nephrol Dial Transplant 2007; 22:3191-3195. (Pubitemid 350202542)
17. Mole CM, Renoult E, Bene MC, et al. Serum secretory IgA and IgM and free secretory components in IgA né phropathy. Nephron 1995; 71:75-78.
18. Zwang JJ, Xu LX, Zhao MH, et al. The level of serum secretory IgA of patients with IgA nephropathy is elevated and associated with pathological phenotypes. Nephrol Dial Transplant 2008; 23:207-212.
19. Mestecky J, Tomana M, Crowley-Nowick PA, et al. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104:172-182.
20. Hiki Y, Tanaka A, Kokubo T, et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Am Soc Nephrol 1998; 9:577-582.
21. Allen AC, Bailey EM, Brenchley PE, et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60:969-973. (Pubitemid 34205796)
22. Smith AC, Molyneux K, Feehally J, Barratt J. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 2006; 17:3520-3528. (Pubitemid 44865295)
23. Smith AC, de Wolff JF, Molyneux K, et al. O-glycosylation of serum IgD in IgA nephropathy. J Am Soc Nephrol 2006; 17:1192-1199.
24. Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 2008; 118:629-639. (Pubitemid 351206552)
25. Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 2007; 71:1148-1154. (Pubitemid 46809135)
26. Li GS, Zhang H, Shen Y, et al. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int 2007; 71:448-453.
27. Li GS, Zhu L, Zhang H, et al. Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy. Hum Mutat 2007; 28:950-957. (Pubitemid 47519387)
28. Malycha F, Egermann T, Hristov M, et al. No evidence for a role of Cosmcchaperone mutations in European IgA nephropathy patients. Nephrol Dial Transplant 2009; 24:321-324.
29. Qin W, Zhong X, Fan JM, et al. External suppression causes the low expression of the Cosmc gene in IgA nephropathy. Nephrol Dial Transplant 2008; 23:1608-1614. (Pubitemid 351767729)
30. Qin W, Zhou Q, Yang LC, et al. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med 2005; 258:467-477. (Pubitemid 41546563)
31. Ding JX, Xu LX, Zhu L, et al. Activity of alpha2,6-sialyltransferase and its gene expression in peripheral B lymphocytes in patients with IgA nephropathy. Scand J Immunol 2009; 69:174-180.
32. Kobayashi I, Nogaki F, Kusano H, et al. Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels. Nephrol Dial Transplant 2002; 17:2108-2116. (Pubitemid 35446665)
33. Chintalacharuvu SR, Emancipator SN. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J Immunol 1997; 159:2327-2333. (Pubitemid 127681024)
34. Yamada K, Kobayashi N, Ikeda T, et al. Down-regulation of core 1 {beta}1,3- galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant 2010; 25:3890-3897.
35. Ogura Y, Suzuki S, Shirakawa T, et al. Haemophilus parainfluenza antigen and antibody in children with IgA nephropathy and Henoch-Schonlein nephritis. Am J Kidney Dis 2000; 36:47-52. (Pubitemid 30432563)
36. Park JS, Song JH, Yang YS, et al. Cytomegalovirus is not specifically associated with immunoglobulin A nephropathy. J Am Soc Nephrol 1994; 4:1623-1626.
37. Tomana M, Novak J, Julian BA, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104:73-81. (Pubitemid 29534347)
38. Suzuki H, Fan R, Zhang Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119:1668-1677.
39. Tomana M, Matousovic K, Julian BA, et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52:509-516. (Pubitemid 27359597)
40. Novak J, Tomana M, Matousovic K, et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67:504-513. (Pubitemid 40139842)
41. Monterio RC. Pathogenic role of IgA receptors in IgA nephropathy. Contrib Nephrol 2007; 157:64-69.
42. Tamouza H, Vende F, Tiwari M, et al. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy. Contrib Nephrol 2007; 157:144-147.
43. Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun 2010; 34:J275-J286.
44. Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006; 17:1724-1734. (Pubitemid 43794676)
45. Oortwijn BD, Eijgenraam JW, Rastaldi MP, et al. The role of secretory IgA and complement in IgA nephropathy. Semin Nephrol 2008; 28: 58-65.
46. Stangou M, Alexopoulos E, Pantzaki A, et al. C5b-9 deposition and tubular alpha3beta1 integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy. Scand J Urol Nephrol 2008; 42:373-380.
47. Allen AC, Bailey EM, Brenchley PE, et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-linked glycosylation: observations on three patients. Kidney Int 2001; 60:969-973. (Pubitemid 34205796)
48. Barratt J, Eitner F, Feehally J, Floege J. Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time. Nephrol Dial Transplant 2009; 24:3620-3623.
49. Barratt J, Smith AC, Moyyneux K, et al. Immunopathogenesis of IgA nephropathy. Semin Immunopathol 2007; 29:427-443.
50. Batra A, Smith AC, Feehally J, et al. T-cell homing receptor expression in IgA nephropathy. Nephrol Dial Transplant 2007; 22:2540-2548. (Pubitemid 47365518)
51. Buren M, Yamashita M, Suzuki Y, et al. Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy. Contrib Nephrol 2007; 157:50-55.
52. Pakkanen SH, Kantele JM, Moldoveanu Z, et al. Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids. Clin Vaccine Immunol 2010; 17:393-401.
53. Sung SS, Bolton WK. T cells and dendritic cells in glomerular disease: the new glomerulotubular feedback loop. Kidney Int 2010; 77:393-399.
54. Agmon-Lewin N, Blank M, Paz Z, Shonfield Y. Molecular mimicry in systemic lupus erythematosus. Lupus 2009; 18:1181-1185.
55. Kokubo T, Hiki Y, Iwase H, et al. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 1997; 8:915-919.
56. Kokubo T, Hiki Y, Iwase H, et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 1998; 9:2048-2054. (Pubitemid 28482152)
57. Suzuki K, Honda K, Tanabe K, et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003; 63:2286-2294. (Pubitemid 36605844)
58. Waldherr R, Rambausek M, Duncker WD, Ritz E. Frequency of mesangial IgA deposits in a nonselected autopsy series. Nephrol Dial Transplant 1989; 4:943-946. (Pubitemid 20050397)
59. Glassock RJ. Analyzing antibody activity in IgA nephropathy. J Clin Invest 2009; 119:1450-1452.
60. Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010; 5;2363-2372.
61. Moriyama T, Nitta K, Suzuki K, et al. Latent IgA deposition from the donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant 2005; 19 (Suppl 14):41-48. (Pubitemid 40990680)
62. Nasr SH, Share DS, Vargas MT, et al. Acute poststaphylococcal glomerulonephritis superimposed on diabetic glomerulosclerosis. Kidney Int 2007; 71:1317-1321. (Pubitemid 46884243)
63. Sharmin S, Shimuzu Y, Hagiwara M, et al. Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol 2004; 17:504-511. (Pubitemid 39302877)
64. Espinosa M, Ortega R, Gomez-Carrasco JM, et al. Mesangial C4d: a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant 2009; 24:886-891.
65. Floege J, van Roeyen D, Boor P, et al. The role of PDGF-D in mesangioproliferative glomerulonephritis. Contrib Nephrol 2007; 157:153-158.
66. Floege J, Ostendorf T. Cytokines and growth factors. In: Lai KN, editor. Recent advances in IgA nephropathy. Singapore: World Scientific; 2009. pp. 243- 266.
67. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19:12-23.
68. Lai KN, Leung JCK. Renin-angiotensin system. In: Recent advances in IgA nephropathy. Singapore: World Scientific,; 2009. pp. 289-308.
69. Coppo R, Amore A, Peruzzi L, et al. Innate immunity and IgA nephropathy. J Nephrol 2010; 23:626-632.
70. De Fijter JW, Eijgenraam JW, Braam CA, et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50:952-961. (Pubitemid 26302685)
71. Suzuki H, Suzuki Y, Narita Y, et al. Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 2008; 19:2384-2395.
72. Maxwell PH, Wang Y. Genetic contribution to IgA nephropathy. In: Lai KN, editor. Recent advances in IgA nephropathy. Singapore: World Scientific; 2009. pp. 21-36.
73. Schena FP, Cerullo G, Tores DD, et al. Searching for IgA nephropathy candidate genes: genetic studies combined with high throughput innovative investigations. Contrib Nephrol 2007; 157:80-89.
74. Lin X, Ding J, Zhu L, et al. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy. Nephrol Dial Transplant 2009; 24:3372-3375.
75. Pirulli D, Crovella S, Ulivi S, et al. Genetic variants of C1GalT1 contributes to the susceptibility to IgA nephropathy. J Nephrol 2009; 22:152-159.
76. Hastings MC, Moldoveanu Z, Julian BA, et al. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability. Clin J Am Soc Nephrol 2010; 5:2069-2074.
77. Gharavi AG, Moldoveanu Z, Wyatt RJ, et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 2008; 19:1008-1014.
78. Feehally J, Farrall M, Boland A, et al. HLA has strongest association with IgA nephropathy in genome-wide studies. J Am Soc Nephrol 2010; 21:1791-1797.